Document is current
Any future updates will be listed below
-
Authors
Solanky, Bhavana S.
Prados, Ferran
Tur, Carmen
Grussu, Francesco
Al-Ahmad, Selma
Yang, Xixi
Bianchi, Alessia
Kanber, Baris
Russo, Antonino
Russo, Vittorio
Choi, David
Panicker, Jalesh N.
Wheeler-Kingshott, Claudia A. M. Gandini
-
Funding
Funding for this research was provided by:
Wings for Life (169111)
Multiple Sclerosis Society (175)
ISCIII
‘la Caixa’ Foundation (100010434)
National Institute for Health and Care Research
MRC (MR/S026088/1)
Ataxia UK
Rosetrees Trust (PGL22/100041)
- License Information
-
More Information
Article History
Received: 19 November 2024
Accepted: 21 February 2025
First Online: 27 February 2025
Declarations
:
: The authors declare no competing interests.
: CT received honoraria from Roche, Novartis, Merck, and Bristol Myers Squibb, and is a steering committee member of the O’HAND trial and of the Consensus group on Follow-on DMTs. CGWK is a shareholder in Queen Square Analytics Ltd.
